immunofluorescence technique using α-actin as described previously (22) . These cells were found 140 to contain high levels of smooth muscle-specific actin. The cells were plated in 75 cm 2 flasks and 141 incubated at 37 o C in 95% air and 5% CO 2 humidified atmosphere in Dulbecco's modified Eagle's 142 medium (DMEM) (with glucose, L-glutamine and sodium bicarbonate) containing antibiotics and 143 10% heat-inactivated fetal bovine serum (FBS). The cells were passaged upon reaching 144 confluence with 0.5% trypsin containing 0.2% EDTA and utilized between passages 3 and 10. 145 Confluent cells were then starved by incubation for 4 h in DMEM without FBS at 37°C to reduce 146 the interference by growth factors present in the serum. For the receptor antagonist studies, 147 VSMC from control and SNP-treated SHR and WKY rats were incubated for 24 h in the absence 148 (control) or presence of losartan (10 μM). After incubation, the cells were washed three times 149 with PBS and lysed in 100 µl of buffer (25 mM Tris-HCl, pH 7.5, 25 mM NaCl, 1 mM Na 150 orthovanadate, 10 mM Na fluoride, 10 mM Na pyrophosphate, 2 mM ethylene, 8 151 bis(oxyethylenenitrolo)tetracetic acid 2 mM ethylenediamine tetracetic acid, 1 mM 152 phenylmethylsulfonyl fluoride, 10 µg/mL aprotinin, 1% Triton X-100, 0.1% sodium dodecyl 153 sulphate (SDS), and 0.5 µg/mL leupeptin) on ice. The cell lysates were centrifuged at 12,000 rpm 154 for 10 min at 4°C, and the supernatants were used for Western blot analysis. Protein concentration 155 was measured with the Bradford assay [23] . Cell viability was checked by the trypan blue 156 exclusion technique as described previously [24] and indicated that >90-95% cells were viable. 157 To examine the role of eNOS in SNP-induced attenuation of hyperproliferation of VSMC from 158 SHR, VSMC from 12 week old male SHR and age-matched WKY rats were preincubated in the 159 absence (control) or presence of N-Nitro-L-Arginine Methyl Ester (L-NAME) (100 μM) for 1 h 160 prior to the treatment with SNP (100 μM) for 24 h and were used for cell proliferation study as 161 described below.
162
Western blotting 163 The levels of protein expression and phosphorylation were determined by Western blotting 164 as described previously (23) . After SDS-PAGE, the separated proteins were transferred to a 165 nitrocellulose membrane with a semi-dry transblot apparatus Mississauga, 166 Ontario, Canada) at 15 V for 45 min or a liquid transfer apparatus (Bio-Rad Laboratories) at 100 167 V for 1 h. Membranes were blocked for 1 h at room temperature with 5% dry milk and incubated 168 overnight with specific primary antibodies against different proteins in phosphate buffer solution 169 (PBS) containing 0.1% Tween-20 (PBS-T) overnight at 4°C. Dynein was used as loading controls 170 in all experiment. The antibody-antigen complexes were detected by incubating the membranes 171 with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. The 172 blots were then washed three times with PBS-T before reaction with enhanced 173 chemiluminescence (ECL). Quantitative analysis of the proteins was performed by densitometric 9 174 scanning of the autoradiographs using the enhanced laser densitometer LKB Ultroscan XL and 175 quantified using the gel-scan XL evaluation software (version 2.1) from Pharmacia (Baie d′Urfé, 176 Québec, Canada).
177

Determination of cell proliferation 178
Cell proliferation was quantified by DNA synthesis which was evaluated by incorporation 179 of [ 3 H] thymidine into cells as described earlier (23). Subconfluent aortic VSMC from control and 180 SNP-treated SHR and their age-matched WKY rats were plated in 6-well plates for 24 h and were 181 serum deprived for 12 h to induce cell quiescence. The cells were then incubated with [ 3 H] 182 thymidine (1 µCi) for 4 h before the cells were harvested. The cells were rinsed twice with ice-183 cold PBS and incubated with 5% trichloroacetic acid (TCA) for 1 h at 4°C. After being washed 184 twice with ice-cold water, the cells were incubated with 0.4 N sodium hydroxide (NaOH) solution 185 for 30 min at room temperature, and radioactivity was determined by liquid scintillation counter.
186
Determination of intracellular levels of nitric oxide (NO)
187
The levels of intracellular NO produced in VSMC were measured using intracellular 188 fluorescent probes diaminofluorescein-2 diacetate (DAF-2DA) as described earlier (18, 19) .
189
Confluent VSMC, after washing twice with PBS, were incubated at 37°C for 1 h with both 10 190 mmol/L DAF-2DA and 10−6 mol/L acetylcholine for detecting NO. Cells were washed twice 191 with PBS, and fluorescence intensities were measured by a spectrophotometer (TECAN infinite 
Results
220
The systolic blood pressure (BP) of SHR and WKY rats at 8 weeks were 184.5 ± 10.3 221 mmHg and 108.5 ± 9.6 mmHg, respectively (p < 0.001). Intraperitoneal injection of SNP to 222 8-week-old SHR (0.5 mg/kg body weight) twice per week decreased the systolic BP in a 223 time-dependent manner and at 10 weeks, the BP was decreased by about 82 mmHg (129.0 ± 5.2 224 vs. 211 ± 8.8 mmHg, p < 0.001) without affecting the BP in WKY rats. In addition, SNP 225 treatment did not have any adverse effects on the health of the animals, because all rats treated 226 with SNP maintained or gained weight during the period of the studies (Body weights at 10 weeks 227 were as follows: WKY rats, 227 ± 5.7 g; SNP-treated WKY rats, 235 ± 3.6 g; SHR, 227 ± 2 g; and 228 SNP-treated SHR, 223 ± 2.4 g). We earlier reported that in vivo treatment of SHR with NO donor SNP attenuated the 242 development of high blood pressure (19) . Since vascular remodeling due to hyperproliferation is 243 associated with hypertension, it was of interest to investigate if in vivo treatment of SHR with 244 SNP could also attenuate the hyperproliferation of VSMC from SHR. As shown in Figure 1 , the 245 proliferation of VSMC from SHR was significantly augmented by about 100% as compared to 246 WKY rats as determined by [ 3 H] thymidine incorporation, and SNP treatment attenuated it by 247 about 50%. On the other hand, SNP did not have any effect on the proliferation of VSMC from 248 WKY rats. 250 We earlier showed that in vivo treatment of SHR with SNP that elevated the intracellular 251 levels of NO also augmented the reduced levels of intracellular eNOS in VSMC from SHR (19). WKY rats by about 40%. Furthermore, the expression of phosphorylated retinoblastoma protein 271 (pRB) (E) that was enhanced by about 180% in VSMC from SHR was also decreased by SNP 272 treatment by about 55%, however, SNP did not affect the levels of pRB in WKY rats. In addition, 273 the levels of RB were not different in VSMC from SHR from WKY rats and SNP did not have 274 any effect on the expression of RB proteins in VSMC from both SHR and WKY rats (E).
249
Implication of eNOS in SNP-induced antiproliferative effect in VSMC from SHR
275
Furthermore, the levels of Cdk inhibitors, p21 Cip1 ( Figure 4A ) and p27 Kip1 ( Figure 4B ) We and others reported earlier that VSMC from SHR exhibit exaggerated cell growth 339 (proliferation) compared to VSMC from WKY rats (4, 5, 25) which was shown to be attributed to 340 the decreased levels of endogenous NO because elevating the intracellular levels of NO by NO 341 donor, SNAP, attenuated the hyperproliferation by cGMP-independent mechanism (18). However,
342
in the present study we show for the first time that in vivo treatment of SHR with SNP that was 343 shown to decrease the high blood pressure (19) diabetic rats (34). However, we report for the first time that in vivo treatment of SHR with SNP 351 that elevated the intracellular levels of NO also attenuates the hyperproliferation of aortic VSMC.
352
The fact that the antiproliferative effect of SNP in VSMC from SHR was reversed by the 
370
The implication of vasoactive peptides in the proliferation of VSMC has been well 371 documented (23, 39). We earlier reported that Ang II, ET-1 and arginine-vasopressin (AVP) 372 increased the proliferation of A10 VSMC via Giα/MAP kinase pathways (23). In addition, Ang II 373 treatment of VSMC from SHR was shown to enhance the proliferation to a greater extent 374 compared to VSMC from WKY rats which was attenuated by Ang II AT1 receptor antagonist, Earlier studies have demonstrated that the enhanced levels of endogenous Ang II through 391 the interaction with AT1 receptor increase oxidative stress which via the activation of c-Src, 392 growth factor receptor and MAP kinase signaling pathways increase the expression of Giα 393 proteins and result in the hyperproliferation of VSMC from SHR (25). In addition, the role of 394 oxidative stress, c-Src, growth factor receptors, MAP kinase and Giα proteins in the 395 overexpression of cell cycle proteins in VSMC from SHR has also been demonstrated (10, 11).
396
Here we show for the first time that in vivo treatment of SHR with SNP inhibits the enhanced 397 activation (phosphorylation) of c-Src, growth factor receptors EGF-R, PDGF-R, and IGF-IR as 398 well as ERK1/2, all the signaling molecules implicated in the proliferation and expression of cell 399 cycle proteins from G1-S phase (10, 11, 43) . These results suggest that the inhibition of enhanced Acknowledgements 427 We also thank the Fonds de recherche du Québec-Nature et technologies (FRQNT) for the merit 428 scholarship (PBEEE) to Ekhtear Hossain at post-doctoral (V2) category (File No.200683 ). WKY rats after pretreatment with L-NAME (100μM) for 1 h were exposed to SNP (100 μM) for 577 24 h.and [3H] thymidine incorporation in these cells was determined as described in the 
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